Projects per year
Fingerprint
Dive into the research topics where Raymond Bergan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 8 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
- 9 Finished
-
-
SPORE in Prostate Cancer
Bergan, R., Jindan, Y., Kaul, K. L., Catalona, W., Jovanovic, B., Abdulkadir, S. A. & Szmulewitz, R.
8/18/15 → 7/31/20
Project: Research project
-
Genistein-mediated Regulation of Prostate Cancer Cell Motility
9/23/08 → 7/31/14
Project: Research project
-
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
Bergan, R. & Bergan, R.
9/30/03 → 9/29/12
Project: Research project
-
Research Output
-
A multifunctional therapy approach for cancer: Targeting Raf1- Mediated inhibition of cell motility, growth, and interaction with the microenvironment
Zhang, L., Pattanayak, A., Li, W., Ko, H. K., Fowler, G., Gordon, R. & Bergan, R., 2020, In : Molecular cancer therapeutics. 19, 1, p. 39-51 13 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone
Graff, J. N., Beer, T. M., Alumkal, J. J., Slottke, R. E., Redmond, W. L., Thomas, G. V., Thompson, R. F., Wood, M. A., Koguchi, Y., Chen, Y., Latour, E., Bergan, R. C., Drake, C. G. & Moran, A. E., Jul 2 2020, In : Journal for immunotherapy of cancer. 8, 2, e00642.Research output: Contribution to journal › Article › peer-review
Open Access -
Genistein treatment duration effects biomarkers of cell motility in human prostate
Zhang, H., Gordon, R., Li, W., Yang, X., Pattanayak, A., Fowler, G., Zhang, L., Catalona, W. J., Ding, Y., Xu, L., Huang, X., Jovanovic, B., Kelly, D. L., Jiang, H. & Bergan, R., Mar 2019, In : PloS one. 14, 3, e0214078.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Involvement of the PI3K/Akt/Nrf2 Signaling Pathway in Resveratrol-Mediated Reversal of Drug Resistance in HL-60/ADR Cells
Li, Y., Guo, Y., Feng, Z., Bergan, R., Li, B., Qin, Y., Zhao, L., Zhang, Z. & Shi, M., Aug 18 2019, In : Nutrition and Cancer. 71, 6, p. 1007-1018 12 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations -
Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential (ESP) Charges
Mishra, R. K., Deibler, K. K., Clutter, M. R., Vagadia, P. P., O'Connor, M., Schiltz, G. E., Bergan, R. & Scheidt, K. A., Jan 1 2019, (Accepted/In press) In : Journal of Chemical Information and Modeling.Research output: Contribution to journal › Article › peer-review
1 Scopus citations